Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women
- 1 November 2001
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 34 (8) , 639-644
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Early Changes in Serum N-Telopeptide and C-Telopeptide Cross-Linked Collagen Type 1 Predict Long-Term Response to Alendronate Therapy in Elderly WomenThe Journal of Clinical Endocrinology & Metabolism, 2000
- Comparison of Serum and Urine Assays for Biochemical Markers of Bone Resorption in Postmenopausal Women with and without Hormone Replacement Therapy and in MenOsteoporosis International, 2000
- Differences in the Capacity of Several Biochemical Bone Markers to Assess High Bone Turnover in Early Menopause and Response to Alendronate TherapyOsteoporosis International, 2000
- Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary IndicesJournal of Bone and Mineral Research, 1999
- Comparison of three serum assays for bone collagen formation during postmenopausal estrogen–progestin therapyClinica Chimica Acta, 1997
- Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human boneBone, 1997
- The aminoterminal propeptide of type I procollagen: Evaluation of a commercial radioimmunoassay kit and values in healthy subjectsClinical Biochemistry, 1997
- Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidismBone, 1996
- Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseasesJournal of Bone and Mineral Research, 1992
- Generation and Application of Data on Biological Variation in Clinical ChemistryCritical Reviews in Clinical Laboratory Sciences, 1989